Dr. Graboski successfully defending her thesis, “Characterization and Inhibition of Gut Microbial Tryptophanase and its Implications in Chronic Kidney Disease” on September 21.
Zoe McElligott, PhD, was one of three UNC addiction medicine researchers featured in Vital Signs. This translational research team is battling the opioid epidemic by analyzing the ever-changing composition of street drugs and testing how emerging drug combination such as xylazine and fentanyl interact in rodent models.
Dr. Sandroni, of Brian Jensen’s Lab, successfully defended his PhD thesis, “The Alpha-1A Adrenergic Receptor Regulates Oxidative Metabolism in the Mouse Heart” on June 26.
Congratulations to Graydon (Grey) Gereau, graduate student from the McElligott lab, on his FIRST first-author paper exploring neurotensin transmission through the brain-body connection!
The competitive award will fund their project titled, “Development of a Novel Platform Approach to Expand the Degradable Proteome.” Congratulations to all!
Dr. Altinok successfully defended her thesis “Domain-Specific Changes in CHIP Function Explain Distinct Clinical Features in SCA48 Patients” on June 6.
Funding from Convergent Research will support the creation of a dataset of all known interactions between small molecule drugs and drug targets, that could be used for drug repurposing or to develop effective drugs with fewer side effects. Learn more about EvE Bio.
Liz Brunk, Ph.D., was featured in an article on CyVerse for her ground breaking development of Jupyter notebooks to facilitate learning through 3D imaging and hands-on experience.
Shelley Earp, MD, receives award honoring UNC systems faculty members who have “made the greatest contribution to the welfare of the human race.”
Dr. Samulski received the Sune Berström award for his pioneering work in gene therapy and adeno-associated virus vectors in the field of pharmacology and molecular virology.
